In one paragraphArticle in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Gabriela Zamora-HerreraLaboratory of Oncoimmunology and Cytomics of Childhood Cancer, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.
Rubí Romo-RodríguezLaboratory of Oncoimmunology and Cytomics of Childhood Cancer, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.ORCID 0000-0002-3715-2337 Jebea A López-BlancoLaboratory of Oncoimmunology and Cytomics of Childhood Cancer, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.ORCID 0000-0003-1274-8289 Laura Alfaro-HernándezLaboratory of Oncoimmunology and Cytomics of Childhood Cancer, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.
Diana Casique-AguirreLaboratory of Oncoimmunology and Cytomics of Childhood Cancer, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.ORCID 0000-0001-5580-2551 Juan Carlos Núñez-EnriquezDivisión de Investigación en Salud, Unidad Médica de Alta Especialidad (UMAE) Hospital de Pediatría "Silvestre Frenk Freund" Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.ORCID 0000-0002-8070-9727 Dalia Ramírez-RamírezLaboratory of Oncoimmunology and Cytomics of Childhood Cancer, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.ORCID 0000-0002-2740-0317 Rosana PelayoLaboratory of Oncoimmunology and Cytomics of Childhood Cancer, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.ORCID 0000-0003-3401-9757 Funding
CONAHCYT FORDECYT-PRONACES 302994Temas Prioritarios de 549 Salud, Población Vulnerable y Temas Emergentes of IMSS R-2023-785-047
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Cell Adhesion MoleculesNeoplasm, ResidualPrecursor B-Cell Lymphoblastic Leukemia-LymphomaAdolescentAntigens, CDChildChild, PreschoolFemaleHumansImmunophenotypingMaleReceptors, G-Protein-CoupledTumor MicroenvironmentADGRE5 protein, humanAntigens, CDCell Adhesion MoleculesReceptors, G-Protein-CoupledCD66cchildhood acute lymphoblastic leukemiaimmune contexturerisk stratificationtumor microenvironment
Identifiers
PMID41827869
PMCPMC12984215
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390